Cancer treatment has evolved significantly with the introduction of targeted therapies like Lynparza used in the treatment of ovarian and breast cancer. This medication represents a specialized class of drugs known as PARP inhibitors. This modern therapy works differently from traditional chemotherapy, making it a vital option for many patients. 

To begin with, the medication targets a specific protein called PARP [poly ADP- ribose polymerase]. PARP plays a crucial role in the repair of damaged DNA. However, cancer cells depend on this process to grow and thrive. If PARP is inhibited or blocked from functioning correctly, it prevents tumor formation due to an inability for these cancer cells to repair damaged DNA and thus stop cellular growth and eventually die, and therefore, healthier cells are less affected.

The medication contains the active ingredient olaparib. This molecule works by blocking the PARP enzyme, a protein that normally helps cells repair damaged DNA. While healthy cells have backup repair systems, many cancer cells especially those with BRCA gene mutation rely heavily on PARP to survive. Consequently, when the medication inhibits this enzyme, the cancer cells cannot fix their DNA, leading to their eventual death.

Healthcare providers prescribe Lynparza 150mg Tablet for metastatic conditions:

• Ovarian, breast, pancreatic and prostate cancers. Many of these uses apply especially to patients whose tumors carry certain genetic changes, like BRCA mutations.
• Additionally, it can treat metastatic cancers where standard treatments have stopped working effectively.

• To achieve the best results, you must follow your doctors precise instructions. The standard daily dose typically comprises two 150mg tablets taken twice daily, means all total 600mg.
• Patients can take the tablets with or without food, and they should swallow them whole without crushing or chewing.
• Avoid consuming grapefruit, Seville oranges, or their juices as these can significantly increase the drugs levels in your blood and lead to severe side effects.
• Moreover, individuals should continue treatments as long as their doctor advises, because stopping early may reduce the benefit of the therapy. 

While the medicine targets cancer cells, it can still affect healthy ones. Common side effects include:

• Nausea
• Fatigue
• Loss of appetite
• Headache
• Dizziness
• Changes in taste.

These issues often occur early in treatment and may lessen over time. However, some patients may experience more serious problems such as :

• Low blood cell counts
• Lung inflammation
• Signs of infections

Warning signs: If a patient experiencing all these severe issues then it requires immediate medical attention. Therefore, healthcare professionals usually monitor patient's blood regularly counts throughout therapy. 

In conclusion, understanding the power and precautions of the medication allows patients and caregivers to make informed choices. Although, this medication does not cure cancer, it can slow tumor growth and extend quality life when used correctly. Therefore, patients should communicate openly with their healthcare team about any symptoms or concerns during therapy. For more information regarding medication visit Globans Pharma website.

 1. Which type of cancer does this medication treat?

This medication treats certain cancers including ovarian, breast, pancreatic, and prostate cancers. It is also effective for people with a BRCA gene mutation or those who have responded well to chemotherapy based on platinum.



2. How does this medication work?

The active ingredient in this medication is olaparib, which belongs to a class of drugs called PARP inhibitor. Therefore, it inhibits PARP protein function by preventing the repair of damaged DNA in a cancer cells allowing them to die off without affecting normal cells.